Elanco Animal Health (ELAN) Revenue (2017 - 2026)

Elanco Animal Health has disclosed Revenue across 10 years of filings, most recently posting $1.4 billion for Q2 2026.

• In Q2 2026, Revenue rose 10.23% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $5.0 billion (up 11.95% YoY), while the FY2025 annual figure was $4.7 billion, up 6.22% from the prior year.
• Revenue came in at $1.4 billion for Q2 2026 at Elanco Animal Health, roughly flat from $1.4 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.4 billion in Q1 2026 to a low of $985.0 million in Q4 2022.
• Average Revenue over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2022.
• Year-over-year, Revenue decreased 11.42% in 2022 and grew 14.92% in 2026.
• Over 5 years, Revenue stood at $985.0 million in 2022, then rose by 5.08% to $1.0 billion in 2023, then decreased by 1.45% to $1.0 billion in 2024, then climbed by 12.16% to $1.1 billion in 2025, then advanced by 19.58% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $1.4 billion in Q2 2026, $1.4 billion in Q1 2026, and $1.1 billion in Q4 2025.